These results suggest that AKT-GSK3β-MYC oncogene addiction hypothesis is not involved in the synthetic lethality, but BETi-induced MYC inhibition still plays a key role in the synthetic lethality in PTEN-deficient CRC cells. The gene discussed is PTEN; the disease is colorectal carcinoma.